use of ventricular enlargement rate in intravenous immunoglobulin treatment of alzheimer''s disease

摘要

The present invention relates to the use of MRI monitoring of ventricular enlargement rate as an objective measure for the purpose of assessing disease progression in patients suffering from Alzheimer"s disease and for the purpose of determining therapeutic effectiveness of a treatment regimen for Alzheimer"s patients. Methods for treating Alzheimer"s Disease and monitoring therapeutic effectiveness are provided.